Wells Fargo
CBIO

Wells Fargo’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-383
Closed -$1.15K 6676
2024
Q1
$1.15K Buy
383
+6
+2% +$18 ﹤0.01% 5726
2023
Q4
$890 Buy
377
+20
+6% +$47 ﹤0.01% 5814
2023
Q3
$536 Sell
357
-18
-5% -$27 ﹤0.01% 5974
2023
Q2
$653 Buy
375
+81
+28% +$141 ﹤0.01% 6121
2023
Q1
$370 Buy
294
+5
+2% +$6 ﹤0.01% 6299
2022
Q4
$876 Buy
289
+7
+2% +$21 ﹤0.01% 5902
2022
Q3
$0 Buy
282
+1
+0.4% ﹤0.01% 6571
2022
Q2
$0 Buy
281
+26
+10% ﹤0.01% 6740
2022
Q1
$0 Buy
255
+1
+0.4% ﹤0.01% 6867
2021
Q4
$0 Buy
254
+1
+0.4% ﹤0.01% 6856
2021
Q3
$1K Sell
253
-49
-16% -$194 ﹤0.01% 6373
2021
Q2
$1K Sell
302
-110,172
-100% -$365K ﹤0.01% 6323
2021
Q1
$333K Buy
110,474
+4,660
+4% +$14K ﹤0.01% 4602
2020
Q4
$398K Buy
105,814
+55,068
+109% +$207K ﹤0.01% 4591
2020
Q3
$155K Sell
50,746
-154,267
-75% -$471K ﹤0.01% 4913
2020
Q2
$771K Buy
205,013
+116,015
+130% +$436K ﹤0.01% 3912
2020
Q1
$203K Buy
88,998
+70,936
+393% +$162K ﹤0.01% 4512
2019
Q4
$96K Buy
18,062
+19
+0.1% +$101 ﹤0.01% 5103
2019
Q3
$78K Buy
18,043
+1,026
+6% +$4.44K ﹤0.01% 5166
2019
Q2
$203K Sell
17,017
-3,406
-17% -$40.6K ﹤0.01% 4783
2019
Q1
$254K Sell
20,423
-4,449
-18% -$55.3K ﹤0.01% 4631
2018
Q4
$236K Buy
24,872
+8,079
+48% +$76.7K ﹤0.01% 4641
2018
Q3
$242K Buy
16,793
+1,075
+7% +$15.5K ﹤0.01% 4734
2018
Q2
$254K Buy
15,718
+15,618
+15,618% +$252K ﹤0.01% 4743
2018
Q1
$2K Hold
100
﹤0.01% 5760
2017
Q4
$2K Buy
+100
New +$2K ﹤0.01% 5743
2017
Q2
Sell
-6,813
Closed -$37K 5851
2017
Q1
$37K Buy
6,813
+2,700
+66% +$14.7K ﹤0.01% 5227
2016
Q4
$25K Hold
4,113
﹤0.01% 5266
2016
Q3
$29K Buy
+4,113
New +$29K ﹤0.01% 5217
2016
Q1
Sell
-25,000
Closed -$143K 5965
2015
Q4
$143K Buy
+25,000
New +$143K ﹤0.01% 4511